Zhang et al. [111] found that oral administration of DBT (3 or 6 g/kg/day for 4 weeks) decreased the concentrations of c-reactive protein and tumour necrosis factor-α and resulted in higher survival rates and lower body weight loss in diabetic GK rats; the diabetic atherosclerosis rats were induced by NO inhibition (I-NAME in drinking water, 1 mg/mL) plus a high-fat diet. Here, CRP is linked to diabetes mellitus.